
Фармсинтез LIFE
Фармсинтез Bilanz 2007-2025 | LIFE
Bilanz Jährlich Фармсинтез
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash And Cash Equivalents |
9.17 M | 15.3 M | 10.4 M | 64.3 M | 233 K | 327 M | 371 M | 7.39 M | 111 M | 505 M | 68.7 M | 3 M | 11.6 M | 22 M | 3.49 M | 6.12 M |
Total Current Assets |
198 M | 206 M | 465 M | 395 M | 505 M | 1.11 B | 1.73 B | 1.42 B | 1.18 B | 1.11 B | 372 M | 646 M | 682 M | 155 M | 159 M | 134 M |
Property Plant Equipment Net |
345 M | 327 M | 352 M | 314 M | 330 M | 412 M | 404 M | 436 M | 465 M | 408 M | 337 M | 48 M | 192 M | 195 M | 207 M | 223 M |
Intangible Assets |
332 M | 400 M | 418 M | 408 M | 409 M | 638 M | 919 M | 338 M | 337 M | 330 M | 64.1 M | - | - | - | - | - |
Goodwill And Intangible Assets |
332 M | 400 M | 418 M | 408 M | 409 M | 1.07 B | 1.22 B | 338 M | 337 M | 330 M | 64.1 M | 320 M | 2.1 M | 2.37 M | 2.65 M | 2.61 M |
Long-Term Investments |
33.5 M | 127 M | 488 M | 4.54 B | 4.69 B | 189 M | 2.53 B | -201 M | -170 M | -31.6 M | 19.5 M | - | - | - | - | - |
Tax Assets |
- | 365 M | 329 M | 218 M | 181 M | 181 M | 108 M | 73.7 M | 30.2 M | 25.9 M | 13.8 M | - | - | - | - | 195 K |
Total Non Current Assets |
1.14 B | 1.22 B | 1.59 B | 5.48 B | 6 B | 2.26 B | 4.4 B | 1.46 B | 1.36 B | 1.05 B | 511 M | 368 M | 216 M | 220 M | 227 M | 242 M |
Total Assets |
1.34 B | 1.43 B | 2.05 B | 5.87 B | 6.5 B | 3.37 B | 6.12 B | 2.87 B | 2.54 B | 2.16 B | 883 M | 1.01 B | 899 M | 375 M | 386 M | 376 M |
Account Payables |
179 M | 141 M | 178 M | 241 M | 517 M | 444 M | 4.91 B | 180 M | 129 M | 52.9 M | 130 M | - | 64.2 M | 73.3 M | 84.5 M | 98.5 M |
Short-Term Debt |
704 M | 621 M | 610 M | 300 M | 23.2 M | 179 M | 226 M | 293 M | 28.9 M | 344 M | 40.7 M | 6 M | 50 K | 21.8 M | 25 M | 8 M |
Tax Payables |
29.2 M | 15.6 M | 12.3 M | 38.5 M | 49.2 M | 35 M | 23.6 M | 34.3 M | 21.2 M | 9.78 M | 6.6 M | - | 10.3 M | 6.96 M | 4.39 M | 2.58 M |
Deferred Revenue |
- | 86 M | 237 M | 104 M | 624 M | 58 M | - | - | 64.6 M | 9.78 M | 6.6 M | - | 12.5 M | 8.96 M | - | - |
Total Current Liabilities |
1.18 B | 993 M | 1.02 B | 1.48 B | 1.32 B | 1.14 B | 962 M | 738 M | 222 M | 436 M | 185 M | 176 M | 606 M | 104 M | 116 M | 111 M |
Long-Term Debt |
41.8 M | 86.8 M | 13.2 M | 141 M | 2.68 M | 53.6 M | - | 2.23 M | 5.6 M | 3.85 M | 1.67 M | - | - | - | - | - |
Deferred Revenue Non Current |
- | - | - | -238 K | -59.7 M | 393 M | - | - | - | - | - | - | - | - | - | - |
Deferred Tax Liabilities Non Current |
- | - | - | 238 K | 32.4 M | 251 K | 177 M | 15.4 M | - | - | - | 11 M | 3.41 M | 572 K | 4.12 M | 1.7 M |
Total Non Current Liabilities |
41.8 M | 86.8 M | 13.2 M | 203 M | 305 M | 447 M | 178 M | 2.23 M | 5.6 M | 3.85 M | 1.67 M | 11 M | 3.41 M | 572 K | 4.12 M | 1.69 M |
Total Liabilities |
1.22 B | 1.08 B | 1.04 B | 1.69 B | 1.62 B | 1.59 B | 1.14 B | 740 M | 228 M | 440 M | 187 M | 187 M | 609 M | 105 M | 120 M | 112 M |
Retained Earnings |
-4.45 B | -4.24 B | -3.54 B | -2.16 B | -1.47 B | -4.4 B | -1.87 B | -963 M | -609 M | -404 M | -256 M | 56 M | 41.9 M | 22.8 M | 18.2 M | 16.2 M |
Accumulated Other Comprehensive Income Loss |
- | -634 M | -663 M | -779 M | -338 M | -521 M | -486 M | -454 M | -412 M | -372 M | -338 M | - | -157 M | - | -123 M | -104 M |
Total Stockholders Equity |
121 M | 345 M | 1.01 B | 4.19 B | 4.88 B | 1.76 B | 4.6 B | 2.13 B | 2.32 B | 1.72 B | 696 M | 827 M | 289 M | 270 M | 266 M | 264 M |
Total Liabilities And Stockholders Equity |
1.34 B | 1.43 B | 2.05 B | 5.87 B | 6.5 B | 3.37 B | 6.12 B | 2.87 B | 2.54 B | 2.16 B | 883 M | 1.01 B | 899 M | 375 M | 386 M | 376 M |
Total Investments |
33.5 M | 125 M | 488 M | 9.8 M | 4.7 B | 241 M | 2.65 B | 137 M | 28.1 M | 27 M | 26.9 M | 342 M | 455 M | 425 K | 425 K | - |
Total Debt |
745 M | 708 M | 624 M | 164 M | 23.2 M | 232 M | 224 M | 295 M | 34.5 M | 348 M | 42.3 M | 6 M | 50 K | 21.8 M | 25 M | 8 M |
Net Debt |
736 M | 693 M | 613 M | 99.4 M | 23 M | -94.4 M | -147 M | 288 M | -76.7 M | -157 M | -26.4 M | 3 M | -11.5 M | -267 K | 21.5 M | 1.88 M |
Alle Zahlen in RUB-Währung
Bilanz Vierteljährlich Фармсинтез
2023-Q2 | 2022-Q4 | 2022-Q2 | 2021-Q4 | 2021-Q2 | 2020-Q4 | 2020-Q2 | 2019-Q4 | 2019-Q2 | 2018-Q4 | 2018-Q2 | 2017-Q4 | 2017-Q2 | 2016-Q4 | 2016-Q2 | 2015-Q4 | 2015-Q2 | 2014-Q4 | 2014-Q2 | 2013-Q4 | 2013-Q2 | 2012-Q4 | 2011-Q4 | 2011-Q2 | 2010-Q4 | 2010-Q2 | 2009-Q4 | 2009-Q2 | 2008-Q4 | 2008-Q2 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash And Cash Equivalents |
257 M | 9.17 M | 2.48 M | 15.3 M | 12 M | 10.4 M | 17.7 M | 66.9 M | 156 K | 4.67 M | 213 M | 327 M | 6.58 M | 371 M | 6.58 M | 7.39 M | 12.3 M | 111 M | 387 M | 505 M | 890 M | 68.7 M | 3 M | 7.3 M | 11.6 M | 16.8 M | 22 M | 12.8 M | 3.49 M | 4.81 M |
Total Current Assets |
563 M | 198 M | 234 M | 206 M | 322 M | 465 M | 506 M | 465 M | 416 M | 586 M | 874 M | 1.11 B | 1.22 B | 1.73 B | 1.22 B | 1.42 B | 1.11 B | 1.18 B | 1.14 B | 1.11 B | 1.37 B | 372 M | 646 M | 664 M | 682 M | 419 M | 155 M | 157 M | 159 M | 146 M |
Property Plant Equipment Net |
341 M | 345 M | 314 M | 327 M | 339 M | 352 M | 362 M | 371 M | 323 M | 379 M | 399 M | 412 M | 412 M | 404 M | 412 M | 436 M | 449 M | 465 M | 451 M | 408 M | 370 M | 337 M | 48 M | 120 M | 192 M | 193 M | 195 M | 201 M | 207 M | 215 M |
Intangible Assets |
394 M | 395 M | 396 M | 400 M | 385 M | 350 M | 356 M | 359 M | 389 M | 382 M | 655 M | 638 M | 333 M | 919 M | 333 M | 338 M | 331 M | 337 M | 19.2 M | 330 M | 83 M | - | - | - | - | - | - | - | - | - |
Goodwill And Intangible Assets |
394 M | 395 M | 396 M | 400 M | 385 M | 350 M | 356 M | 359 M | 389 M | 382 M | 1.09 B | 1.07 B | 333 M | 1.22 B | 333 M | 338 M | 331 M | 337 M | 19.2 M | 330 M | 83 M | 64.1 M | 320 M | 161 M | 2.1 M | 2.24 M | 2.37 M | 2.51 M | 2.65 M | 2.63 M |
Long-Term Investments |
42.5 M | 33.5 K | 63.3 M | 127 M | 468 M | 488 M | 902 M | 731 M | 4.46 B | 2.92 B | 170 M | 189 M | 1.46 B | 2.53 B | 1.42 B | -201 M | 27.9 M | -39.6 M | -12.5 M | -25 M | 27 M | 19.5 M | - | - | - | - | - | - | - | - |
Tax Assets |
- | 367 M | 342 M | 365 M | 348 M | 329 M | 350 M | 327 M | 205 M | - | 233 M | 181 M | 97.8 M | 108 M | 97.8 M | 73.7 M | - | 30.2 M | 22.4 M | 25.9 M | 20.6 M | 13.8 M | - | - | - | - | - | - | - | 97.5 K |
Total Non Current Assets |
1.15 B | 1.14 B | 1.12 B | 1.22 B | 1.54 B | 1.59 B | 1.97 B | 1.96 B | 5.75 B | 3.97 B | 2.25 B | 2.26 B | 2.39 B | 4.4 B | 2.39 B | 1.46 B | 1.18 B | 1.36 B | 882 M | 1.05 B | 600 M | 511 M | 368 M | 292 M | 216 M | 218 M | 220 M | 223 M | 227 M | 235 M |
Total Assets |
1.72 B | 1.34 B | 1.35 B | 1.43 B | 1.86 B | 2.05 B | 2.48 B | 2.43 B | 6.17 B | 4.55 B | 3.12 B | 3.37 B | 3.61 B | 6.12 B | 3.61 B | 2.87 B | 2.3 B | 2.54 B | 2.02 B | 2.16 B | 1.97 B | 883 M | 1.01 B | 956 M | 899 M | 637 M | 375 M | 381 M | 386 M | 381 M |
Account Payables |
300 M | 179 M | 390 M | 141 M | 217 M | 623 M | 696 M | 241 M | 1.09 B | 287 M | 486 M | 284 M | 202 M | 278 M | 202 M | 246 M | 154 M | 129 M | 113 M | 60.4 M | 380 M | 130 M | - | 32.1 M | 64.2 M | 68.8 M | 73.3 M | 78.9 M | 84.5 M | 91.5 M |
Short-Term Debt |
720 M | 704 M | 546 M | 621 M | 382 M | 389 M | 170 M | 300 M | 35.9 M | 275 M | 194 M | 179 M | 592 M | 318 M | 592 M | 293 M | 16.8 M | 28.9 M | 31.8 M | 344 M | 72.7 M | 40.7 M | 6 M | 3.02 M | 50 K | 10.9 M | 21.8 M | 23.4 M | 25 M | 16.5 M |
Tax Payables |
- | 29.2 M | - | 15.6 M | - | - | - | 38.5 M | - | - | 40.9 M | 35 M | 22.3 M | 23.6 M | 22.3 M | 34.3 M | - | 21.2 M | 9.45 M | 9.78 M | 4.64 M | 6.6 M | - | 5.13 M | 10.3 M | 8.61 M | 6.96 M | 5.68 M | 4.39 M | 3.48 M |
Deferred Revenue |
- | - | - | 86 M | - | - | - | 104 M | 273 M | - | 578 M | - | - | - | - | - | - | 64.6 M | 10.3 M | 9.78 M | 19.3 M | 6.6 M | - | 6.23 M | 12.5 M | 10.7 M | 8.96 M | 4.48 M | - | - |
Total Current Liabilities |
1.04 B | 1.18 B | 937 M | 993 M | 1.06 B | 1.02 B | 981 M | 920 M | 1.56 B | 1.01 B | 1.26 B | 1.14 B | 1.05 B | 962 M | 1.05 B | 738 M | 297 M | 222 M | 155 M | 436 M | 472 M | 185 M | 176 M | 391 M | 606 M | 355 M | 104 M | 110 M | 116 M | 113 M |
Long-Term Debt |
40.8 M | 41.8 M | 56.5 M | 86.8 M | 50.1 M | 13.2 M | 105 M | 141 M | 54.3 M | 62.4 M | 104 M | 53.6 M | 727 K | - | 727 K | 2.23 M | 4.34 M | 5.6 M | 3.37 M | 3.85 M | 3.16 M | 1.67 M | - | - | - | - | - | - | - | - |
Deferred Revenue Non Current |
- | - | - | - | - | - | - | 592 K | -54.3 M | - | - | - | - | - | - | - | - | - | -8.56 M | - | 5.07 M | - | - | - | - | - | - | - | - | - |
Deferred Tax Liabilities Non Current |
- | - | - | - | - | - | - | 238 K | 32.8 M | - | 274 K | 251 K | - | 177 M | - | - | - | - | 8.56 M | - | -5.07 M | - | 11 M | 7.21 M | 3.41 M | 1.99 M | 572 K | 2.35 M | 4.12 M | 2.91 M |
Total Non Current Liabilities |
40.8 M | 41.8 M | 68.5 M | 86.8 M | 50.4 M | 13.2 M | 105 M | 141 M | 81.9 M | 63 M | 515 M | 447 M | 727 K | 178 M | 727 K | 2.23 M | 7.83 M | 5.6 M | 11.9 M | 3.85 M | 8.23 M | 1.67 M | 11 M | 7.21 M | 3.41 M | 1.99 M | 572 K | 2.35 M | 4.12 M | 2.91 M |
Total Liabilities |
1.08 B | 1.22 B | 1.01 B | 1.08 B | 1.11 B | 1.04 B | 1.09 B | 1.06 B | 1.64 B | 1.08 B | 1.77 B | 1.59 B | 1.05 B | 1.14 B | 1.05 B | 740 M | 305 M | 228 M | 167 M | 440 M | 480 M | 187 M | 187 M | 398 M | 609 M | 357 M | 105 M | 112 M | 120 M | 116 M |
Retained Earnings |
-4.61 B | -4.45 B | -4.3 B | -4.24 B | -3.79 B | -3.54 B | -3.12 B | -3.02 B | -1.82 B | -1.19 B | -4.99 B | -4.4 B | -451 M | -1.87 B | -451 M | -963 M | -892 M | -609 M | -797 M | -404 M | -563 M | -256 M | 56 M | 48.9 M | 41.9 M | 32.4 M | 22.8 M | 20.5 M | 18.2 M | 17.2 M |
Accumulated Other Comprehensive Income Loss |
- | -469 K | -568 M | -634 M | -678 M | -663 M | -689 M | -779 M | -345 M | -313 M | 189 M | -521 M | - | -486 M | 295 M | -454 M | 173 M | 396 M | -390 M | 8.21 M | -342 M | -338 M | - | -78.6 M | -157 M | -78.6 M | - | -61.4 M | -123 M | -114 M |
Total Stockholders Equity |
636 M | 121 M | 345 M | 345 M | 747 M | 1.01 B | 1.39 B | 1.36 B | 4.53 B | 3.47 B | 1.35 B | 1.76 B | 2.56 B | 4.6 B | 2.56 B | 2.13 B | 1.99 B | 2.32 B | 1.85 B | 1.72 B | 1.49 B | 696 M | 827 M | 558 M | 289 M | 280 M | 270 M | 268 M | 266 M | 265 M |
Total Liabilities And Stockholders Equity |
1.72 B | 1.34 B | 1.35 B | 1.43 B | 1.86 B | 2.05 B | 2.48 B | 2.43 B | 6.17 B | 4.55 B | 3.12 B | 3.37 B | 3.61 B | 6.12 B | 3.61 B | 2.87 B | 2.3 B | 2.54 B | 2.02 B | 2.16 B | 1.97 B | 883 M | 1.01 B | 956 M | 899 M | 637 M | 375 M | 381 M | 386 M | 381 M |
Total Investments |
42.5 M | 33.5 M | 61.6 M | 125 M | 468 M | 488 M | 902 M | 731 M | 4.47 B | 2.92 B | 170 M | 241 M | 1.54 B | 2.65 B | 1.54 B | 137 M | 241 M | 28.1 M | 27.1 M | 27 M | 27 M | 26.9 M | 342 M | 398 M | 455 M | 228 M | 425 K | 425 K | 425 K | 212 K |
Total Debt |
761 M | 745 M | 603 M | 708 M | 432 M | 402 M | 275 M | 255 M | 35.9 M | 333 M | 298 M | 232 M | 593 M | 224 M | 593 M | 295 M | 21.2 M | 34.5 M | 35.2 M | 348 M | 75.8 M | 42.3 M | 6 M | 3.02 M | 50 K | 10.9 M | 21.8 M | 23.4 M | 25 M | 16.5 M |
Net Debt |
504 M | 736 M | 600 M | 693 M | 420 M | 391 M | 257 M | 188 M | 35.8 M | 329 M | 84.9 M | -94.4 M | 586 M | -147 M | 586 M | 288 M | 8.87 M | -76.7 M | -352 M | -157 M | -814 M | -26.4 M | 3 M | -4.27 M | -11.5 M | -5.91 M | -267 K | 10.6 M | 21.5 M | 11.7 M |
Alle Zahlen in RUB-Währung